Titan Biotech Ltd

Titan Biotech Other Announcement

Titan Biotech has dispatched letters to shareholders with unregistered emails, providing web links to access the FY 2025-26 Annual Report and 34th AGM Notice.

Titan Biotech Annual Report

Titan Biotech filed its 34th Annual Report and AGM Notice for the financial year 2025-26. The AGM is scheduled for September 29, 2026.

Titan Biotech Dividend

Titan Biotech Limited has fixed September 22, 2026, as the record date for a final dividend of ₹0.50 per share. The payout remains subject to shareholder approval.

Titan Biotech Annual General Meeting

Titan Biotech Limited will hold its 34th Annual General Meeting on September 29, 2026. The company set September 22, 2026, as the record date for final dividend eligibility.

Titan Biotech Bonus Issue

Titan Biotech Limited approved a 1:4 bonus issue and increased its authorised share capital to Rs. 10.40 Crore. The bonus issue is subject to shareholder approval at the upcoming AGM.

Value

₹2.07 Cr

Titan Biotech Q1 FY27 Results: Net Profit ₹10.9 Cr, Up 58.0% YoY

Titan Biotech Ltd reported revenue from operations of ₹59.2 Cr (+27.3% YoY) and net profit of ₹10.9 Cr (+58.0% YoY) for Q1 FY27.

Key figure

Net profit ₹10.9 Cr · +58.0% YoY

Titan Biotech Q4 FY26 Results: Net Profit ₹6.7 Cr, Up 67.5% YoY

Titan Biotech Ltd reported revenue from operations of ₹48.8 Cr (+38.6% YoY) and net profit of ₹6.7 Cr (+67.5% YoY) for Q4 FY26.

Key figure

Net profit ₹6.7 Cr · +67.5% YoY